These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 13783494)

  • 41. Use of spironolactone in renal edema. Effectiveness and association with hyperkalemia.
    MANNING RT; BEHRLE FC
    JAMA; 1961 Jun; 176():769-71. PubMed ID: 13766245
    [No Abstract]   [Full Text] [Related]  

  • 42. [Comments on the use of spirolactones in the treatment of ascitic cirrhosis (5 cases)].
    GRILLIAT JP; MARCHAL C; ANTOINE ; SAPELIER P; KIFFER B
    Rev Med Nancy; 1961; 86():801-20. PubMed ID: 13901929
    [No Abstract]   [Full Text] [Related]  

  • 43. [Spirolactones in the treatment of ascitogenic hepatic cirrhosis. Clinical and biological effects].
    BONINI A
    Minerva Med; 1962 Jun; 53():1990-4. PubMed ID: 13871015
    [No Abstract]   [Full Text] [Related]  

  • 44. [Spirolactones. Their use in the treatment of cardiac and cirrhotic edemas (apropos of 6 case reports)].
    JUSTIN-BESANCON L; LAROCHE C; NENNA A; ETIENNE JP; CREMER G
    Sem Hop; 1960 Dec; 36():3083-97. PubMed ID: 13791128
    [No Abstract]   [Full Text] [Related]  

  • 45. [Aldactone (aldosterone antagonist SC-9, 420) in the treatment of the edemas of heart patients and cirrhotic patients. Bioclinical study].
    PAGET M; LANGERON L; CROCCEL L; ROUTIER G; CROCCEL E; PROTIN M
    J Sci Med Lille; 1962 May; 80():225-35. PubMed ID: 14483183
    [No Abstract]   [Full Text] [Related]  

  • 46. [Aldactone (antialdosterone SC-9420) in the treatment of the edema of cardiac and cirrhoticpatients. Bioclinical study. I].
    PAGET M; LANGERON L; CROCCEL L; ROUTIER G; CROCCEL E
    Ann Biol Clin (Paris); 1962; 20():497-524. PubMed ID: 14483184
    [No Abstract]   [Full Text] [Related]  

  • 47. [Hypokalemis, hypochloremia and alkalosis in the long-term treatment of edematous heart insufficiency with benzothiadiazine diuretics. III. Effects of spirolactone].
    OLESEN K; SANDOE E
    Ugeskr Laeger; 1962 Jul; 124():1037-41. PubMed ID: 14481741
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of spirolactone SC 8109 on renal function in normal human subjects.
    WIGGINS RA; HUTCHIN ME; CARBONE JV; DOOLAN PD
    Proc Soc Exp Biol Med; 1959 Mar; 100(3):625-7. PubMed ID: 13634231
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of heparinoid and spirolactone on the renal excretion of sodium and aldosterone.
    CEJKA V; de VRIES L; van DAATSELAAR J; BORST JG; MAJOOR CL
    Lancet; 1960 Feb; 1(7119):317-9. PubMed ID: 13808736
    [No Abstract]   [Full Text] [Related]  

  • 50. The diuretic effect of spirolactone SC-9420 in a case of secondary aldosteronism.
    CEJKA V; de VRIES L; BORST JG
    Lancet; 1960 Feb; 1(7119):312-4. PubMed ID: 13808735
    [No Abstract]   [Full Text] [Related]  

  • 51. [ALDOSTERONE ANTAGONISTS IN THE TREATMENT OF CIRRHOTIC ASCITIS].
    GARCIA-RAMOSARRIAGA J
    Acta Med Tenerife; 1963; 20():101-4. PubMed ID: 14093724
    [No Abstract]   [Full Text] [Related]  

  • 52. [Aldosterone and spirolactones].
    VESIN P
    Concours Med; 1961 Feb; 83():597-604. PubMed ID: 13781053
    [No Abstract]   [Full Text] [Related]  

  • 53. [THE ANTIDIURETIC EFFECT OF DIURETICS AND ITS APPLICATION TO THE TREATMENT OF DIABETES INSIPIDUS DURING INFANCY. A COMPARATIVE STUDY O BETWEEN TRICHLORMETHIAZIDE, CHLORTHALIDONE AND SPIROLACTONE].
    PENA J; RON J; NESTAL A
    Rev Clin Esp; 1963 Nov; 91():175-80. PubMed ID: 14108797
    [No Abstract]   [Full Text] [Related]  

  • 54. [RENAL CLEARANCE OF FREE ALDOSTERONE BEFORE AND AFTER APPLICATION OF AN ALDOSTERONE ANTAGONIST].
    GFELLER J
    Z Gesamte Exp Med; 1964 Oct; 138():353-65. PubMed ID: 14316605
    [No Abstract]   [Full Text] [Related]  

  • 55. The clinical application of aldosterone antagonists in the treatment of oedema.
    SHALDON S
    Proc R Soc Med; 1961 Apr; 54(4):259-61. PubMed ID: 13750628
    [No Abstract]   [Full Text] [Related]  

  • 56. The SPIROLACTONES.
    Br Med J; 1960 Jul; 2(5195):364-5. PubMed ID: 13856752
    [No Abstract]   [Full Text] [Related]  

  • 57. [Spirolactone. Its use in the treatment of cardiac and cirrhotic edema. Apropos of 6 case reports].
    JUSTIN-BESANCON L; LAROCHE C; NENNA A; ETIENNE JP; CREMER G
    Sem Hop Ther Paris; 1961 Mar; 37():197-211. PubMed ID: 13791127
    [No Abstract]   [Full Text] [Related]  

  • 58. Studies on the metabolic effects of spironolactone in man.
    HOOD WG; HILL R; PITTMAN JA; FARMER TA
    Ann N Y Acad Sci; 1960 Oct; 88():864-80. PubMed ID: 13715691
    [No Abstract]   [Full Text] [Related]  

  • 59. [Aldosterone-antagonistic spirolactones. II. Clinical aspects].
    HILD R; KRUECK F
    Klin Wochenschr; 1961 Feb; 39():178-81. PubMed ID: 13714208
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of aldosterone antagonist (SC 9420) on periodic paralysis.
    OKINAKA S; OHSAWA N; SHIZUME K; MOTOHASHI K; FUJITA T; MURAKAWA S; MATSUZAKI F; MORII H; UCHIKAWA T
    J Clin Endocrinol Metab; 1962 May; 22():549-51. PubMed ID: 14481568
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.